A five-laboratory coordinated study was undertaken to determine whether ticarcillin and ticarcillinclavulanic acid disk susceptibility tests could accurately detect resistance among enteric bacilli. Each facility performed disk tests and broth microdilution susceptibility tests with reagents distributed from a common source, and appropriate controls were included in order to ensure methodologic uniformity. Each institution tested 500 consecutively isolated enteric bacilli against ticarcillin and ticarcillin-clavulanic acid. The prevalence of discrepancies between disk tests and dilution tests with 2,435 unselected enteric bacilli provided a valid estimate of the true error rate for tests with the two disks. The current interpretive criteria for susceptibility tests with ticarcillin and ticarcillin-clavulanic acid disks were found to be reliable; i.e., there were major or very major discrepancies between MIC categories and disk test results for less than 1% of all strains and minor discrepancies for only 5 to 10%. Even lower error rates would occur if the zone size-interpretive criteria were modified, but at this time it is difficult to determine whether the practical problems created by making such changes can be justified by the magnitude of the problem that is being resolved.
enzymes that were able to resist inhibition by clavulanic acid. Escherichia coli and Klebsiella spp. comprised the majority of these exceptionally resistant strains. Sanders et al. (6) proposed a modification of the zone size-interpretive criteria for ticarcillin-clavulanic acid disk tests in order to minimize false-susceptible disk test results that may occur when enteric bacilli that produce high levels of plasmidmediated 1-lactamases are tested.
In 1989, Fuchs et al. (2) evaluated the situation in order to consider altering the zone size criteria for ticarcillin-clavulanic acid disk tests. They concluded that the modified zone size criteria of Sanders et al. (s18 mm for resistant and -23 mm for susceptible) would indeed eliminate most very major errors with the unusually resistant strains, but that change was not recommended because minor error rates would be markedly increased because of the large proportion of truly susceptible strains that would be placed in the intermediate or moderately susceptible category. The decision to modify zone size-interpretive criteria for ticarcillin-clavulanic acid disk tests will depend on the prevalence of strains that give false-susceptible disk test results compared with the prevalence of susceptible strains that would be miscategorized as being moderately susceptible. In this report, we describe the results of a five-laboratory survey that was designed to document the true prevalence of interpretive discrepancies * Corresponding author.
when 75-,ug ticarcillin or 75-,ug ticarcillin-10-,ug clavulanic acid disk tests were performed against consecutively isolated members of the family Enterobacteriaceae. The survey provided a data base that was unbiased by prior selection of unusually resistant strains or by the disproportionate distribution of species that are normally selected for evaluating disk tests.
MATERIALS AND METHODS
Testing facilities. The directors of each laboratory that collaborated in this study and the five clinical laboratories were as follows: Peter C. Fuchs (4, 5) . Broth microdilution trays were prepared and distributed to the participating laboratories by Prepared Media Laboratories, Tualatin, Oreg. The broth microdilution trays contained twofold dilutions of ticarcillin (256 to 2.0 jig/ml). The ticarcillin was tested alone, with 2 jig of clavulanic acid per ml, and with 16 ,ug of clavulanic acid per ml. The 16-,ug/ml test system was included in an effort to identify strains that were resistant to the combination by virtue of a ,-lactamase-mediated system that could be neutralized by the excess inhibitor. Antimicrobial disks included 75-,ug ticarcillin or 75-,ug ticarcillin-10-,ug clavulanic acid disks and were distributed from a common source.
Throughout the study, each participant performed at least 20 replicate tests with each of three quality control strains (E. coli ATCC 25922 and ATCC 35218 and Pseudomonas aeruginosa ATCC 27853). Staphylococcus aureus ATCC 25923 was also tested by the disk method. Furthermore, to document comparability among testing facilities, 20 reference strains were tested in all five clinical laboratories and by the coordinating facility. These reference strains included 10 E. coli (5 ticarcillin-resistant), 5 Klebsiella pneumoniae (3 ticarcillin-resistant and 2 moderately susceptible), and 5 Citrobacterfreundii (4 ticarcillin-resistant) strains. Because these control data documented comparability, data from the five testing facilities were combined for this report.
Study design. Each testing facility performed broth microdilution and disk diffusion susceptibility tests with all isolates belonging to the family Enterobacteriaceae that were judged significant enough to be identified and subjected to routine susceptibility tests. The number of patients from whom these isolates were recovered was not considered for this type of microorganism sample. The studies in each institution continued until at least 500 consecutive isolates were evaluated. This provided an unbiased collection of clinical isolates that were encountered from November 1990 through January 1991. The majority (65%) of all isolates were obtained from urine cultures, 11% were from respiratory tract specimens, 7% were from blood cultures, and 18% were from other sources. As expected, E. coli predominated in this type of sample. Discrepancies between broth microdilution and disk diffusion test results were then expressed in terms of error rates that would be expec,ted in the clinical laboratory rather than those that might be expected with the extremely biased challenge sets of microorganisms that are appropriately used in the initial evaluation of disk diffusion susceptibility testing criteria.
RESULTS
Repeatability. Data accumulated with 20 reference strains were evaluated before the studies began. All six testing laboratories reported similar test results. For each strain, the range of zone diameters recorded by six laboratories varied from 1 to 7 mm and the average range was 3.4 mm (with ticarcillin) or 4.4 mm (with ticarcillin-clavulanic acid). Reported MICs varied over ranges of 2 or 3 doubling dilutions, averaging 1.2 dilution intervals for ticarcillin-clavulanic acid and 2.5 dilution steps for ticarcillin. The commonly accepted variation of ±1 doubling dilution (2-dilution interval ranges) was met with the majority of isolates. Regression analysis demonstrated that such a 2-dilution interval range in MICs was approximately comparable to an 8-mm range in zone diameters. In that sense, agar diffusion disk tests were more reproducible than broth microdilution susceptibility tests.
Quality control data reported throughout the studies also documented an acceptable level of reproducibility. Two quality control strains of E. coli (ATCC 25922 and ATCC 35218) were tested 108 times, and >95% of all reported MICs were within the acceptable limits that are defined for tests with ticarcillin or ticarcillin-clavulanic acid (4 Table 1 summarizes the results of broth microdilution tests with the three dominant genera and with all strains combined. At 16 ,ug/ml, ticarcillin inhibited 61% of all enteric bacilli, and the addition of 2 ,ug of clavulanic acid per ml added another 23% to the susceptible category. When the concentration of clavulanic acid was further increased to 16 ,g/ml, nearly all enteric bacilli were susceptible to 16 jxg of ticarcillin per ml. The 30 strains that were resistant to 128 ,ug of ticarcillin per ml with 16 ,ug of clavulanic acid per ml included 23 Enterobacter cloacae, 4 C. freundii, and 2 Serratia liquefaciens strains and 1 Morganella morganii strain. All but 2 of those 30 strains that were resistant to the combination with 16 ,ug/ml were also very resistant to ticarcillin and ticarcillin-clavulanic acid as determined by MIC testing and by disk test. The two exceptions were E. cloacae strains that were susceptible to both drugs as determined by MIC testing and by disk test. At 16 ,ug/ml, clavulanic acid appeared to be antagonistic for those two isolates, but they were not available for us to confirm that antagonism. We concluded that among enteric bacilli, resistance to ticarcillin is nearly all due to P-lactamase enzymes that can be neutralized in vitro when enough clavulanic acid is added to the system. Among the 1,335 E. coli isolates, 25% were resistant to ticarcillin but only 6% were resistant to ticarcillin-clavulanic acid. The latter isolates are presumed to be the hyperproducers of P-lactamase that Sanders et al. described (6), because they were rendered susceptible by increasing the amount of clavulanic acid. MICs for strains in the moderately susceptible category occurred with 11% of all E. coli isolates tested against ticarcillin-clavulanic acid. It is difficult to know whether these strains will be clinically responsive to therapy with the combination, but all of those strains were rendered susceptible when the concentration of inhibitor was increased. The latter strains were previously considered susceptible (MIC, s64 ,ug/ml-2 ,ug/ml for ticarcillin-clavulanic acid) (1, 3) , and no clinical problems with the previous categorization have yet been reported.
Klebsiella species tended to be resistant to ticarcillin, but 92% were susceptible to s16 ,ug of ticarcillin per ml with 2 jig of clavulanic acid per ml. At 64 and 2 ,g/ml, ticarcillinclavulanic acid inhibited another 4% of the Klebsiella species. All but three strains were susceptible to 16 ,ug/ml when the amount of clavulanic acid was increased.
The Enterobacter species presented a somewhat different picture, since the addition of clavulanic acid (2 ,ug/ml) had very little effect on the overall susceptibility to ticarcillin. Approximately 80% of all Enterobacter spp. were susceptible or moderately susceptible to ticarcillin and to ticarcillinclavulanic acid. Further increase in clavulanic acid left only 9% resistant to ticarcillin. For the purposes of this study, the role of type I P-lactamase enzymes that are typically produced by these microorganisms is unclear, since they should not be inhibited by the clavulanic acid.
Ticarcillin disk tests. The interpretive agreements between ticarcillin MIC categories and disk test results are illustrated in Fig. 1 and summarized in Table 2 . For tests with 75-,ug ticarcillin disks, strains with zones s14 mm in diameter were resistant, those with zones 15 to 19 mm in diameter were moderately susceptible, and those with zones .20 mm in Ticarcillin-clavulanic acid disk tests. Figure 2 presents the results of tests with all enteric bacilli, comparing ticarcillinclavulanic acid MICs and zone size categories. Table 3 summarizes discrepant results with two zone size criteria (.14 and .20 mm contrasted with <18 and .23 mm). By broth microdilution tests, 84% of all enteric bacilli were susceptible and 7% were resistant. With the proposed breakpoints of s18 and .23 mm, 84% were susceptible and 8% were resistant. By the current zone site criteria, 90% of all enteric bacilli were susceptible and only 3% were resistant.
Very major error rates, expressed as the percentage of 166 strains that were determined to be resistant by MIC testing, were reduced from 10% with the current criteria to 2% with the proposed criteria. For E. coli isolates, very major errors y, not necessarily the total number tested. Disks contained 75 ,ug of ticarcillin.
dropped from 6 to 0%. At the same time, the proportion of strains with zone sizes that put them in the moderately susceptible category increased from 6% by the current method to 9% by the proposed method. Among E. coli isolates, that figure changed from 8 to 11%. With Klebsiella spp. and Enterobacter spp., the proportion of strains with intermediate zone sizes did not change greatly.
Error rates for tests with 75-p.g ticarcillin-10-,ug clavulanic acid disks are summarized in Table 4 . If very major errors are recorded as the percentage of all strains tested, the rate for strains of the Enterobacteriaceae is 0.8% and modification of the zone size standards would reduce that to 0.2%. At the same time, major error rates would be increased from 0.05 to 0.2% and the proportion of strains with moderately susceptible disk test results would increase from 6 to 9%. If the very major error rates are expressed as the percentage of strains in the resistant category as determined by MIC tests, the rate is 10% by the current zone standards but only 2% by the proposed standards. For E. coli isolates alone, the same very major error rates are 6 and 0%. For Enterobacter spp., very major error rates would be reduced from 8 to 6% (1.6 and 1.2% of the total number of strains tested).
DISCUSSION
In the first edition of the NCCLS standard for antimicrobial dilution susceptibility tests (3) , microorganisms for which the MICs are .64 p.g/ml were defined as susceptible to ticarcillin or ticarcillin with 2 jig of clavulanic acid per ml. Disks containing ticarcillin and clavulanic acid (75 and 10 jug, respectively) were also evaluated with two zone size criteria. The extended zone size criteria propo''sed by Sanders et al. (6) did indeed reduce the total number of very major errors from 0.8 to 0.2% (10% of resistant strains to 2% of resistant strains). At the same time, the number of strains falling into the moderately susceptible disk test category increased from 6 to 9% (by dilution tests, 9% of enteric bacilli were moderately susceptible). Among the strains that were fully susceptible as determined by MIC testing, 6 were moderately susceptible and 1 was resistant by the current zone standards, whereas 68 would be moderately susceptible and 3 would be resistant if the proposed standards were used. Among E. coli strains, the 1% very major error rate was completely eliminated but the number of moderately susceptible strains increased from 8 to 11%. With Klebsiella spp., there were no very major errors with either disk criterion but minor errors were 5 and 8% with the two zone size criteria.
The overall agreement between MIC categories and disk susceptibility test results was slightly improved by applying the interpretive zone size criteria of Sanders et al. (6) . When there were discrepancies, it was difficult to determine which of the two tests would better predict the clinical outcome. In the absence of compelling clinical data which docu'ment failure of the current criteria, we are reluctant to recommend yet another change in interpretive breakpoints. There is a very real need for clinical data that will help to evaluate the utility of ticarcillin or ticarcillin-clavulanic acid in treating infections due to microorganisms which were initially considered susceptible but are now categorized as being moderately susceptible (MIC, 32 or 64 p.g/ml). If such microorganisms are truly nonresponsive, they should be categorized as resistant and revised zone size criteria will be needed. However, at this time, there is no reason to believe that enteric bacilli for which MICs are c64 ,ug/ml will fail to respond to therapy. False-susceptible ticarcillin-clavulanic acid disk test results do occur, but this happens with less than 1% of all enteric bacilli. That low error rate could be further reduced by changing the zone size breakpoints, but it is difficult to determine whether the practical problems created by making changes in interpretive criteria can be justified by the magnitude of the problem that is being resolved.
